Policy Brief
Realizing the Benefits of Biosimilars: Overcoming Rebate Walls
Nitzan Arad, Elizabeth Staton, Marianne Hamilton Lopez, Samson Goriola, Aparna Higgins, Mark McClellan, Barak Richman
2022
Read MoreWhite Paper
Blog Entry
Priorities And Policy Levers To Support School-Located Vaccination
Katie Huber, Katie Greene, John Bollinger
Health Affairs, 2022
Read MoreOp-Ed
America needs a confirmed leader at FDA — now
Mark McClellan, Scott Gottlieb, and Margaret Hamburg and Andy Slavitt
2022
Read More